Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTNNA3 antisense RNA 1 (CTNNA3-AS1) is a long non-coding RNA transcribed from the antisense strand of the CTNNA3 gene locus. Unlike protein-coding genes, CTNNA3-AS1 does not encode a protein, and its biological roles are likely related to regulating the expression of the CTNNA3 gene or other loci through RNA-based mechanisms. CTNNA3 itself encodes α-T-catenin, a protein involved in cell-cell adhesion with roles in tumor suppression and cardiac biology[1][2]. There is currently limited information in the literature about the specific biological or disease roles of CTNNA3-AS1, as research has largely focused on the protein-coding CTNNA3 gene[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTNNA3 antisense RNA 1 (CTNNA3-AS1).